CRBU Caribou Biosciences, Inc. - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 13, 2026
$1.22
· % 处于52周区间
· 高于低点
· 至高点
$1.2252周低点
$3.5452周高点
市值 (MRQ)
$129M
P/E (TTM)
-1.1
EPS (TTM)
$-1.08
收入 (TTM)
$10M
CRBU 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$1.22
市值 (MRQ)
$129M
P/E (TTM)
-1.1
EPS (TTM)
$-1.08
收入 (TTM)
$10M
ROE (TTM)
-78.3%
52周区间
$1–$4
CRBU 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
收入$11M2019-12-31 → 2025-12-31
EPS$-1.592021-12-31 → 2025-12-31
自由现金流$-112M2021-12-31 → 2025-12-31
净利率-1030.4%2021-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | CRBU | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -1.15年均值 ≈-3.4 | ≈-3.4 | · | · | |
| P/S (TTM) | 12.95年均值 ≈33.1 | ≈33.1 | 40.4 | 低估 | |
| 市净率 (MRQ) | 1.35年均值 ≈1.4 | ≈1.4 | 2.4 | 低估 | |
| 股价/自由现金流 (TTM) | -1.45年均值 ≈-7.5 | ≈-7.5 | · | · | |
| 市现率 (TTM) | -1.45年均值 ≈-8.0 | ≈-8.0 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 1.05年均值 ≈1.4 | ≈1.4 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | CRBU | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | -1090.9%5年均值 ≈-959.8% | ≈-959.8% | -3077.6% | 顶尖 | |
| 息税折旧摊销前利润率 (TTM) | -1065.1%5年均值 ≈-939.0% | ≈-939.0% | -3077.6% | 顶尖 | |
| Pretax Margin (税前利润率) | -1332.3%5年均值 ≈-906.2% | ≈-906.2% | -3779.8% | 顶尖 | |
| 净利润率 (TTM) | -1030.4%5年均值 ≈-906.1% | ≈-906.1% | -3650.4% | 顶尖 | |
| ROA (TTM) | -56.9%5年均值 ≈-35.7% | ≈-35.7% | -66.8% | 持平 | |
| ROE (TTM) | -78.3%5年均值 ≈-46.8% | ≈-46.8% | -108.3% | 持平 | |
| ROIC | -121.0%5年均值 ≈-54.2% | ≈-54.2% | -98.3% | 低于平均水平 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | CRBU | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 6.55年均值 ≈9.8 | ≈9.8 | 4.2 | 流动性强 | |
| Quick Ratio (速动比率) | 0.55年均值 ≈2.9 | ≈2.9 | 1.7 | 低流动性 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | CRBU | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 11.7%5年均值 ≈22.3% | ≈22.3% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | -7.0%5年均值 ≈11.7% | ≈11.7% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | -2.0% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | CRBU | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.05年均值 ≈0.0 | ≈0.0 | 0.0 | 顶尖 | |
| Receivables Turnover (应收账款周转率) | 66.85年均值 ≈69.5 | ≈69.5 | 4.7 | 顶尖 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$115.0K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
5.8%
下次报告
十一月 09, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 13, 2026 | $-0.24 | $-0.32 | 25.7% |
| 2026年3月31日 | $-0.26 | $-0.32 | 19.8% | |
| 2025年12月31日 | $-0.28 | $-0.32 | 11.4% | |
| 2025年9月30日 | $-0.30 | $-0.37 | 18.4% | |
| 2025年6月30日 | $-0.58 | $-0.40 | -45.1% | |
| 2025年3月31日 | $-0.43 | $-0.45 | 4.7% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $11M | $10M | $34M | $14M | $10M | $12M | |
| R&D Expense | $109M | $130M | $112M | $82M | $52M | $34M | |
| SG&A Expense | $38M | $46M | $38M | $38M | $24M | $14M | |
| Operating Expenses | $160M | $177M | $151M | $120M | $77M | $48M | |
| Operating Income | $-148M | $-167M | $-116M | $-106M | $-67M | $-36M | |
| Interest Expense | · | · | · | · | $8.0K | $20.0K | |
| Other Non-op | $-331.0K | $18M | $14M | $7M | $377.0K | $-3.0K | |
| Pretax Income | $-149M | $-149M | $-102M | $-99M | $-67M | $-36M | |
| Income Tax | $-550.0K | $-9.0K | $193.0K | $70.0K | $321.0K | $-2M | |
| Net Income | $-148M | $-149M | $-102M | $-99M | $-67M | $-34M | |
| EPS (Basic) | $-1.59 | $-1.65 | $-1.38 | $-1.64 | $-2.11 | · | |
| EPS (Diluted) | $-1.59 | $-1.65 | $-1.38 | $-1.64 | $-2.11 | · | |
| Shares (Basic) | 93,389,283 | 90,317,925 | 73,807,597 | 60,801,133 | 31,663,243 | · | |
| Shares (Diluted) | 93,389,283 | 90,317,925 | 73,807,597 | 60,801,133 | 31,663,243 | · | |
| EBITDA | $-145M | $-163M | $-113M | $-105M | $-66M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $12M | $16M | $51M | $58M | $240M | $16M | |
| Short-term Investments | · | · | · | · | $135M | $0 | |
| Receivables | $69.0K | $265.0K | $148.0K | $202.0K | $1M | $150.0K | |
| Prepaid Expense | $3M | $7M | $6M | $8M | $7M | $3M | |
| Current Assets | $145M | $219M | $339M | $260M | $391M | $24M | |
| PP&E (Net) | $7M | $19M | $18M | $11M | $5M | $4M | |
| PP&E (Gross) | $20M | $32M | $27M | $16M | $9M | $7M | |
| Accum. Depreciation | $14M | $13M | $9M | $6M | $4M | $3M | |
| Other Non-current Assets | $2M | $6M | $2M | $2M | $975.0K | $612.0K | |
| Total Assets | $175M | $313M | $432M | $374M | $442M | $36M | |
| Accounts Payable | $6M | $2M | $3M | $1M | $4M | $3M | |
| Accrued Liabilities | $17M | $24M | $21M | $16M | $13M | $9M | |
| Current Liabilities | $25M | $31M | $28M | $28M | $26M | $12M | |
| Capital Leases | $26M | $25M | $26M | $27M | $0 | · | |
| Deferred Tax | $0 | $548.0K | $557.0K | $381.0K | $476.0K | $155.0K | |
| Total Liabilities | $53M | $60M | $64M | $73M | $55M | $18M | |
| Common Stock | $9.0K | $9.0K | $8.0K | $6.0K | $6.0K | $1.0K | |
| Paid-in Capital | $719M | $701M | $668M | $500M | $486M | $7M | |
| Retained Earnings | $-597M | $-448M | $-299M | $-197M | $-98M | $-31M | |
| AOCI | $103.0K | $255.0K | $30.0K | $-2M | $-135.0K | $0 | |
| Stockholders' Equity | $122M | $253M | $368M | $301M | $388M | $-23M | |
| Liabilities + Equity | $175M | $313M | $432M | $374M | $442M | $36M | |
| Shares Outstanding | 95,143,690 | 92,378,577 | 88,448,948 | 61,029,184 | 60,263,158 | 9,710,829 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $2M | $984.0K | $900.0K | |
| Stock-based Comp | $13M | $17M | $14M | $12M | $3M | $1M | |
| Deferred Tax | $-551.0K | $-10.0K | $178.0K | $-95.0K | $320.0K | $-919.0K | |
| Other Non-cash | $21M | $-10M | $-9M | $-5M | $30M | · | |
| Operating Cash Flow | $-111M | $-138M | $-93M | $-91M | $-33M | $-33M | |
| CapEx | $1M | $5M | $12M | $6M | $2M | $317.0K | |
| Investing Cash Flow | $102M | $87M | $-68M | $-93M | $-176M | $6M | |
| Stock Issued | $4M | $15M | $1M | $0 | · | · | |
| Net Stock Activity | $4M | $15M | $1M | · | · | · | |
| Financing Cash Flow | $5M | $17M | $154M | $2M | $433M | $2M | |
| Net Change in Cash | $-4M | $-35M | $-7M | $-182M | $225M | $-25M | |
| Taxes Paid | · | $0 | $170.0K | $0 | $11.0K | $21.0K | |
| Free Cash Flow | $-112M | $-143M | $-105M | $-97M | $-35M | · | |
| Levered FCF | · | · | · | · | $-35M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -1329.4% | -1667.2% | -336.6% | -768.2% | -697.8% | · | |
| Net Margin | -1327.4% | -1491.9% | -296.1% | -717.8% | -697.3% | · | |
| Pretax Margin | -1332.3% | -1492.0% | -295.5% | -717.3% | -693.9% | · | |
| EBITDA Margin | -1296.7% | -1627.9% | -326.4% | -756.5% | -687.6% | · | |
| ROA | -60.6% | -40.0% | -25.3% | -24.4% | -28.0% | · | |
| ROE | -102.8% | -55.8% | -26.6% | -31.8% | -16.9% | · | |
| ROIC | -121.0% | -65.9% | -31.6% | -35.4% | -17.3% | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 7.2 | 12.0 | 9.3 | 15.1 | · | |
| Quick Ratio | 0.5 | 0.5 | 1.8 | 2.1 | 9.4 | · | |
| Interest Coverage | · | · | · | · | -8372.4 | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | · | |
| Receivables Turnover | 66.8 | 48.4 | 197.0 | 20.4 | 14.7 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.28 | $2.74 | $4.17 | $4.93 | $6.44 | · | |
| Revenue / Share | $0.12 | $0.11 | $0.47 | $0.23 | · | · | |
| Cash Flow / Share | $-1.19 | $-1.53 | $-1.26 | $-1.50 | · | · | |
| Cash / Share | $0.13 | $0.18 | $0.58 | $0.96 | $3.99 | · | |
| EPS (TTM) | $-1.59 | $-1.65 | $-1.38 | $-1.64 | $-2.11 | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.7% | -71.0% | 148.9% | 44.3% | -22.4% | · | |
| Revenue CAGR 3Y | -7.0% | 1.4% | 40.8% | · | · | · | |
| Revenue CAGR 5Y | -2.0% | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $11M | $10M | $34M | $14M | $10M | · | |
| Net Income TTM | $-148M | $-149M | $-102M | $-99M | $-67M | · | |
| Market Cap | $151M | $147M | $507M | $383M | $909M | · | |
| P/E | -1.0 | -1.0 | -4.2 | -3.8 | -7.2 | · | |
| P/S | 13.6 | 14.7 | 14.7 | 27.7 | 94.7 | · | |
| P/B | 1.2 | 0.6 | 1.4 | 1.3 | 2.3 | · | |
| P / Tangible Book | 1.2 | 0.6 | 1.4 | 1.3 | 2.3 | · | |
| P / Cash Flow | -1.4 | -1.1 | -5.4 | -4.2 | -28.0 | · | |
| P / FCF | -1.3 | -1.0 | -4.8 | -3.9 | -26.3 | · | |
| Earnings Yield | -100.0% | -103.8% | -24.1% | -26.1% | -14.0% | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $2M | $4M | $2M | $3M | $2M | $2M | $2M | $3M | $2M | $4M | $24M | $4M | $4M | $4M | $3M | |
| R&D Expense | $19M | $21M | $24M | $22M | $28M | $36M | $30M | $30M | $35M | $34M | $31M | $29M | $27M | $26M | $26M | $20M | |
| SG&A Expense | $8M | $8M | $9M | $9M | $10M | $10M | $10M | $10M | $11M | $15M | $10M | $10M | $10M | $9M | $9M | $10M | |
| Operating Expenses | $27M | $29M | $32M | $32M | $50M | $45M | $41M | $40M | $47M | $48M | $41M | $38M | $37M | $35M | $34M | $30M | |
| Operating Income | $-25M | $-26M | $-28M | $-29M | $-48M | $-43M | $-39M | $-38M | $-44M | $-46M | $-37M | $-15M | $-33M | $-31M | $-31M | $-27M | |
| Other Non-op | $1M | $1M | $1M | $2M | $-7M | $3M | $3M | $4M | $6M | $5M | $3M | $5M | $3M | $3M | $4M | $-110.0K | |
| Income Tax | · | $0 | $-550.0K | $0 | · | $0 | $-9.0K | $0 | $0 | $0 | $193.0K | $0 | $0 | $0 | $70.0K | $0 | |
| Net Income | $-24M | $-25M | $-26M | $-28M | $-54M | $-40M | $-35M | $-35M | $-38M | $-41M | $-35M | $-10M | $-30M | $-28M | $-27M | $-27M | |
| EPS (Basic) | $-0.24 | $-0.26 | $-0.28 | $-0.30 | $-0.58 | $-0.43 | $-0.39 | $-0.38 | $-0.42 | $-0.46 | $-0.32 | $-0.12 | $-0.48 | $-0.46 | $-0.44 | $-0.44 | |
| EPS (Diluted) | $-0.24 | $-0.26 | $-0.28 | $-0.30 | $-0.58 | $-0.43 | $-0.39 | $-0.38 | $-0.42 | $-0.46 | $-0.32 | $-0.12 | $-0.48 | $-0.46 | $-0.44 | $-0.44 | |
| Shares (Basic) | 100,985,698 | 95,861,716 | · | 93,293,099 | 93,028,698 | 92,679,493 | · | 90,455,900 | 90,340,932 | 89,302,937 | · | 83,783,992 | 61,417,934 | 61,186,514 | · | 60,886,921 | |
| Shares (Diluted) | 100,985,698 | 95,861,716 | · | 93,293,099 | 93,028,698 | 92,679,493 | · | 90,455,900 | 90,340,932 | 89,302,937 | · | 83,783,992 | 61,417,934 | 61,186,514 | · | 60,886,921 | |
| EBITDA | $-25M | $-26M | · | $-29M | $-48M | $-42M | · | $-38M | $-44M | $-45M | · | $-15M | · | · | · | $-27M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $26M | $12M | $12M | $11M | $25M | $29M | $16M | $32M | $38M | $49M | $51M | $104M | $66M | $53M | $58M | $82M | |
| Receivables | $203.0K | $227.0K | $69.0K | $242.0K | $71.0K | $88.0K | $265.0K | $184.0K | $215.0K | $917.0K | $148.0K | $1M | $766.0K | $2M | $202.0K | $397.0K | |
| Prepaid Expense | $2M | $2M | $3M | $5M | $6M | $6M | $7M | $7M | $6M | $7M | $6M | $7M | $6M | $6M | $8M | $9M | |
| Current Assets | $117M | $122M | $145M | $156M | $193M | $217M | $219M | $237M | $271M | $305M | $339M | $351M | $269M | $239M | $260M | $307M | |
| PP&E (Net) | $5M | $6M | $7M | $8M | $8M | $19M | $19M | $20M | $20M | $19M | $18M | $17M | $15M | $13M | $11M | $9M | |
| PP&E (Gross) | $20M | $20M | $20M | $20M | $20M | $33M | $32M | $31M | $31M | $29M | $27M | $25M | $22M | $19M | $16M | $14M | |
| Accum. Depreciation | $15M | $14M | $14M | $13M | $12M | $14M | $13M | $12M | $11M | $10M | $9M | $8M | $7M | $6M | $6M | $5M | |
| Other Non-current Assets | $2M | $2M | $2M | $4M | $4M | $5M | $6M | $5M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | |
| Total Assets | $143M | $149M | $175M | $195M | $221M | $274M | $313M | $344M | $373M | $407M | $432M | $458M | $350M | $347M | $374M | $399M | |
| Accounts Payable | $3M | $4M | $6M | $4M | $3M | $4M | $2M | $3M | $3M | $6M | $3M | $2M | $4M | $3M | $1M | $1M | |
| Accrued Liabilities | $13M | $14M | $17M | $19M | $21M | $20M | $24M | $25M | $24M | $19M | $21M | $18M | $16M | $13M | $16M | $15M | |
| Current Liabilities | $18M | $20M | $25M | $28M | $29M | $28M | $31M | $32M | $31M | $29M | $28M | $25M | $34M | $27M | $28M | $29M | |
| Capital Leases | $25M | $26M | $26M | $23M | $24M | $24M | $25M | $25M | $26M | $26M | $26M | $26M | $26M | $26M | $27M | $27M | |
| Deferred Tax | · | · | $0 | $548.0K | $548.0K | $548.0K | $548.0K | $557.0K | $557.0K | $556.0K | $557.0K | $381.0K | $380.0K | $382.0K | $381.0K | $475.0K | |
| Total Liabilities | $45M | $47M | $53M | $53M | $55M | $56M | $60M | $63M | $62M | $64M | $64M | $59M | $80M | $69M | $73M | $75M | |
| Common Stock | $11.0K | $10.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Paid-in Capital | $744M | $724M | $719M | $712M | $709M | $705M | $701M | $693M | $689M | $684M | $668M | $664M | $525M | $504M | $500M | $496M | |
| Retained Earnings | $-646M | $-622M | $-597M | $-570M | $-542M | $-488M | $-448M | $-413M | $-378M | $-341M | $-299M | $-265M | $-255M | $-225M | $-197M | $-170M | |
| AOCI | $-71.0K | $-23.0K | $103.0K | $93.0K | $40.0K | $167.0K | $255.0K | $789.0K | $-319.0K | $-322.0K | $30.0K | $-981.0K | $-1M | $-730.0K | $-2M | $-2M | |
| Stockholders' Equity | $98M | $102M | $122M | $142M | $166M | $217M | $253M | $281M | $310M | $343M | $368M | $398M | $269M | $278M | $301M | $324M | |
| Liabilities + Equity | $143M | $149M | $175M | $195M | $221M | $274M | $313M | $344M | $373M | $407M | $432M | $458M | $350M | $347M | $374M | $399M | |
| Shares Outstanding | 105,995,653 | 96,951,234 | 95,143,690 | 93,468,038 | 93,123,239 | 93,004,602 | 92,378,577 | 90,552,687 | 90,362,771 | 90,314,501 | 88,448,948 | 88,430,609 | 66,100,039 | 61,323,523 | 61,029,184 | 60,986,936 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $625.0K | $649.0K | $682.0K | $631.0K | $1M | $1M | $1M | $1M | $856.0K | $710.0K | $740.0K | $2M | $617.0K | $589.0K | $506.0K | $450.0K | |
| Stock-based Comp | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $4M | $4M | $3M | $4M | $3M | $3M | $3M | |
| Restructuring | · | · | · | · | · | · | · | $600.0K | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-5M | · | · | · | $-2M | · | · | · | $-667.0K | · | · | · | · | · | · | |
| Operating Cash Flow | $-23M | $-27M | $-21M | $-25M | $-28M | $-37M | $-35M | $-33M | $-33M | $-37M | $-21M | $-29M | $-15M | $-28M | $-25M | $-22M | |
| CapEx | $1.0K | $72.0K | $-216.0K | $115.0K | $418.0K | $1M | $518.0K | $673.0K | $2M | $1M | $2M | $5M | $3M | $2M | $2M | $1M | |
| Investing Cash Flow | $19M | $24M | $18M | $11M | $24M | $49M | $16M | $27M | $21M | $23M | $-31M | $-68M | $11M | $21M | $1M | $-8M | |
| Stock Issued | $18M | $2M | $4M | $0 | $0 | $0 | $4M | $0 | $0 | $11M | $0 | $-1.0K | $-115.0K | $1M | $0 | $0 | |
| Net Stock Activity | · | $2M | · | · | · | $0 | · | · | · | $11M | · | · | · | · | · | · | |
| Financing Cash Flow | $18M | $3M | $4M | $277.0K | $6.0K | $468.0K | $4M | $244.0K | $132.0K | $12M | $-43.0K | $135M | $18M | $2M | $127.0K | $654.0K | |
| Net Change in Cash | $14M | $-303.0K | $1M | $-14M | $-4M | $13M | $-16M | $-6M | $-12M | $-2M | $-53M | $38M | $13M | $-6M | $-24M | $-30M | |
| Taxes Paid | · | · | · | · | · | · | · | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Free Cash Flow | · | $-27M | · | · | · | $-38M | · | · | · | $-39M | · | · | · | · | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1690.4% | -1096.4% | · | -1337.6% | -1784.0% | -1823.8% | · | -1889.2% | -1255.8% | -1893.9% | · | -61.8% | · | · | · | -803.4% | |
| Net Margin | -1619.9% | -1046.5% | · | -1253.3% | -2028.4% | -1699.6% | · | -1713.6% | -1088.2% | -1697.6% | · | -42.3% | · | · | · | -806.8% | |
| EBITDA Margin | -1690.4% | -1069.3% | · | -1337.6% | -1784.0% | -1774.2% | · | -1889.2% | -1255.8% | -1864.6% | · | -61.8% | · | · | · | -803.4% | |
| ROA | -13.4% | -11.9% | · | -10.2% | -18.2% | -11.8% | · | -8.6% | -10.4% | -10.9% | · | -2.3% | · | · | · | -6.2% | |
| ROE | -18.4% | -15.7% | · | -13.0% | -22.7% | -14.3% | · | -10.2% | -13.0% | -13.3% | · | -2.8% | · | · | · | -7.3% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.5 | 6.2 | · | 5.5 | 6.7 | 7.6 | · | 7.4 | 8.8 | 10.5 | · | 14.3 | · | · | · | 10.7 | |
| Quick Ratio | 1.5 | 0.6 | · | 0.4 | 0.9 | 1.0 | · | 1.0 | 1.2 | 1.7 | · | 4.3 | · | · | · | 2.9 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | · | · | · | 0.0 | |
| Receivables Turnover | 10.9 | 15.2 | · | 10.3 | 18.7 | 4.7 | · | 3.1 | 7.1 | 2.0 | · | 30.9 | · | · | · | 6.8 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.93 | $1.05 | · | $1.52 | $1.78 | $2.34 | · | $3.11 | $3.44 | $3.80 | · | $4.50 | · | · | · | $5.31 | |
| Revenue / Share | $0.01 | $0.03 | · | $0.02 | $0.03 | $0.03 | · | $0.02 | $0.04 | $0.03 | · | $0.28 | · | · | · | $0.05 | |
| Cash Flow / Share | · | $-0.28 | · | · | · | $-0.40 | · | · | · | $-0.42 | · | · | · | · | · | · | |
| Cash / Share | $0.25 | $0.12 | · | $0.12 | $0.27 | $0.32 | · | $0.35 | $0.42 | $0.55 | · | $1.18 | · | · | · | $1.35 | |
| EPS (TTM) | $-1.08 | $-1.42 | · | $-1.70 | $-1.78 | $-1.62 | · | $-1.58 | $-1.32 | $-1.38 | · | $-1.50 | $-1.82 | $-1.66 | · | $-1.11 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | $11M | · | $9M | $9M | $10M | · | $11M | $33M | $33M | · | $35M | $15M | $14M | · | $13M | |
| Net Income TTM | $-103M | $-133M | · | $-157M | $-164M | $-148M | · | $-148M | $-123M | $-115M | · | $-95M | $-111M | $-100M | · | $-91M | |
| Market Cap | $187M | $184M | · | $218M | $117M | $85M | · | $177M | $148M | $464M | · | $423M | · | · | · | $643M | |
| P/E | -1.6 | -1.3 | · | -1.4 | -0.7 | -0.6 | · | -1.2 | -1.2 | -3.7 | · | -3.2 | -2.3 | -3.2 | · | -9.5 | |
| P/S | 18.6 | 16.4 | · | 23.4 | 12.9 | 8.6 | · | 15.5 | 4.5 | 13.9 | · | 12.2 | · | · | · | 50.6 | |
| P/B | 1.9 | 1.8 | · | 1.5 | 0.7 | 0.4 | · | 0.6 | 0.5 | 1.4 | · | 1.1 | · | · | · | 2.0 | |
| P / Tangible Book | 1.9 | 1.8 | · | 1.5 | 0.7 | 0.4 | · | 0.6 | 0.5 | 1.4 | · | 1.1 | 1.0 | 1.2 | · | 2.0 | |
| P / Cash Flow | · | -6.8 | · | · | · | -2.3 | · | · | · | -12.5 | · | · | · | · | · | · | |
| Earnings Yield | -61.4% | -74.7% | · | -73.0% | -141.3% | -177.4% | · | -80.6% | -80.5% | -26.9% | · | -31.4% | -42.8% | -31.3% | · | -10.5% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $11M | $10M | $34M | $14M | $10M |
| 营业利润率 % | -1329.4% | -1667.2% | -336.6% | -768.2% | -697.8% |
| 净收入 | $-148M | $-149M | $-102M | $-99M | $-67M |
| 稀释后每股收益 (EPS) | $-1.59 | $-1.65 | $-1.38 | $-1.64 | $-2.11 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 5.7 | 7.2 | 12.0 | 9.3 | 15.1 |
| 速动比率 | 0.5 | 0.5 | 1.8 | 2.1 | 9.4 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-112M | $-143M | $-105M | $-97M | $-35M |
机构持有人 (13F) 148 家申报者 · $89.6M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
148
持有价值
$89.6M
新仓位
26
已退出持仓
22
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 26 (-4 与上一季度对比) | 22 (+11 与上一季度对比) | 45 (+14 与上一季度对比) | 28 (-10 与上一季度对比) | +10.5M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| BlackRock, Inc. | $13755883 | 7815843 | 15.36% | 股份 |
| Pfizer Inc | $7879924 | 4690431 | 8.80% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $7407080 | 4208568 | 8.27% | 股份 |
| VANGUARD GROUP INC | $6843676 | 4304198 | 7.64% | 股份 |
| MACKENZIE FINANCIAL CORP | $6425401 | 3650796 | 7.17% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $4881439 | 2773545 | 5.45% | 股份 |
| Kynam Capital Management, LP | $4405812 | 2503302 | 4.92% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $4180624 | 2374894 | 4.67% | 股份 |
| STATE STREET CORP | $2873929 | 1632914 | 3.21% | 股份 |
| BANK OF AMERICA CORP /DE/ | $2483287 | 1410958 | 2.77% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $1841451 | 1046279 | 2.06% | 股份 |
| TWO SIGMA ADVISERS, LP | $1773963 | 1115700 | 1.98% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $1716629 | 975327 | 1.92% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1365424 | 775809 | 1.52% | 股份 |
| FMR LLC | $1279722 | 727115 | 1.43% | 股份 |
| NORTHERN TRUST CORP | $1254819 | 712965 | 1.40% | 股份 |
| MAVERICK CAPITAL LTD | $1148474 | 652542 | 1.28% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1080290 | 613801 | 1.21% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $1067243 | 606388 | 1.19% | 股份 |
| Qube Research & Technologies Ltd | $960529 | 545755 | 1.07% | 股份 |
| UBS Group AG | $910573 | 517371 | 1.02% | 股份 |
| 72 Investment Holdings, LLC | $834358 | 474067 | 0.93% | 股份 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $723323 | 410979 | 0.81% | 股份 |
| MARSHALL WACE, LLP | $661205 | 375686 | 0.74% | 股份 |
| Green Alpha Advisors, LLC | $641210 | 364324 | 0.72% | 股份 |
| PFM Health Sciences, LP | $624249 | 354687 | 0.70% | 股份 |
| GOLDMAN SACHS GROUP INC | $568260 | 322875 | 0.63% | 股份 |
| Invesco Ltd. | $529966 | 301117 | 0.59% | 股份 |
| WELLS FARGO & COMPANY/MN | $525035 | 298315 | 0.59% | 股份 |
| XTX Topco Ltd | $473716 | 269157 | 0.53% | 股份 |
| Bruce & Co., Inc. | $440000 | 250000 | 0.49% | 股份 |
| Man Group plc | $422516 | 240066 | 0.47% | 股份 |
| Bank of New York Mellon Corp | $391706 | 222560 | 0.44% | 股份 |
| MILESTONE ASSET MANAGEMENT, LLC | $352150 | 200085 | 0.39% | 股份 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $305140 | 173375 | 0.34% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $291129 | 165414 | 0.33% | 股份 |
| Susquehanna Portfolio Strategies, LLC | $279131 | 158597 | 0.31% | 股份 |
| Graham Capital Management, L.P. | $274409 | 155914 | 0.31% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $247421 | 140580 | 0.28% | 股份 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $232320 | 132000 | 0.26% | 股份 |
| Nuveen, LLC | $217388 | 123516 | 0.24% | 股份 |
| CITADEL ADVISORS LLC | $217008 | 123300 | 0.24% | 买入期权 |
| Cubist Systematic Strategies, LLC | $216135 | 92762 | 0.24% | 股份 |
| LPL Financial LLC | $216082 | 122774 | 0.24% | 股份 |
| MORGAN STANLEY | $213523 | 121320 | 0.24% | 股份 |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $206800 | 117500 | 0.23% | 股份 |
| DEUTSCHE BANK AG\ | $157652 | 89575 | 0.18% | 股份 |
| Quadrature Capital Ltd | $156603 | 88979 | 0.17% | 股份 |
| CANADA PENSION PLAN INVESTMENT BOARD | $142736 | 81100 | 0.16% | 股份 |
| Keystone Financial Group | $142252 | 80825 | 0.16% | 股份 |
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| The City Canyon Family Trust dated May 31, 2021, Rachel E. Haurwitz, Felix Adler ×3 申报 | 2025年4月25日 | 5.00% | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 18 位内幕人士 · 9 位高管 · 7 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Rachel E. Haurwitz | President and CEO | 2026年2月20日 A | 447150 | 0 | 0 | $0 |
| Sriram Ryali | Chief Financial Officer | 2026年2月20日 A | 72360 | 0 | 0 | $0 |
| Jason O'Byrne | Chief Financial Officer | 2024年2月20日 A | 59224 | 0 | 0 | $0 |
| Timothy P Kelly | Chief Technology Officer | 2026年2月25日 S | 73125 | 0 | 2 | $-18188 |
| Tina M. Albertson | Chief Medical Officer | 2026年2月20日 A | 68523 | 0 | 1 | $-2089 |
| Ruhi Ahmad Khan | Chief Business Officer | 2026年2月20日 A | 104998 | 0 | 1 | $-13598 |
| Steven Kanner | Chief Scientific Officer | 2025年2月20日 A | 431556 | 0 | 0 | $0 |
| Ryan Fischesser | VP of Finance and Controller | 2024年11月20日 A | 118854 | 0 | 0 | $0 |
| Syed Ali-Aamir Rizvi | Chief Medical Officer | 2023年2月21日 A | 59373 | 0 | 0 | $0 |
| Dara Richardson-Heron | 董事 | 2026年2月20日 A | · | 0 | 0 | $0 |
| Ran Zheng | 董事 | 2026年2月20日 A | · | 0 | 0 | $0 |
| Nancy Whiting | 董事 | 2026年2月20日 A | · | 0 | 0 | $0 |
| David Lee Johnson | 董事 | 2026年2月20日 A | · | 0 | 0 | $0 |
| Natalie Sacks | 董事 | 2026年2月20日 A | · | 0 | 0 | $0 |
| Scott Braunstein | 董事 | 2026年2月20日 A | · | 0 | 0 | $0 |
| Barbara G Mcclung | · | 2026年2月20日 A | 481564 | 0 | 1 | $-13598 |
| Andrew Guggenhime | · | 2026年2月20日 A | · | 0 | 0 | $0 |
| FMR LLC | · | 2021年7月27日 C | 1464775 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 15 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| OMFS · Invesco Exchange-Traded Self-Inde... | 0.08% | 164575 SH | 2026年10月2日 | 每日 |
| IWC · iShares Trust | 0.03% | 319257 SH | 2026年9月11日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 79869 SH | 2026年8月19日 | 每日 |
| IBB · iShares Trust | 0.01% | 670052 SH | 2026年9月11日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.01% | 6958 SH | 2026年10月2日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 131852 SH | 2026年10月2日 | 每日 |
| RSSL · Global X Funds | 0.00% | 43883 NS | 2026年7月31日 | N-PORT |
| IWM · iShares Trust | 0.00% | 2250647 SH | 2026年9月11日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.00% | 255338 NS | 2026年7月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 74931 NS | 2026年7月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 1113215 SH | 2026年8月19日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 3013973 SH | 2026年8月19日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.00% | 524917 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 9015 SH | 2026年8月19日 | 每日 |
| IWN · iShares Trust | · | 875712 SH | 2026年9月11日 | 每日 |
CRBU 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 13 位分析师
买入
中位数目标
$10.00
+719.7%
5 38.5%
强烈买入
7 53.8%
买入
1 7.7%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
7 位分析师 · 2026-10-02平均目标 $11.86 +871.9%
← 低于所有目标
当前价格 $1.22
最低$4.00
平均值$11.86
最高$32.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | · |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | · |
| OTLK | $57M | -0.6 | · | -4416.2% | 193.1% | 4.0% |
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | · |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | · |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | · |
| SPRB | $120M | -1.7 | -51.3% | · | -139.9% | · |
| TNYA | $154M | -1.2 | · | · | -81.2% | · |
| CBUS | · | -0.6 | -14.6% | -3492.3% | -223.0% | · |
| INO | $120M | -1.0 | -70.0% | -130000.0% | -322.8% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 13, 2026 申报